MSH2 and hepatocellular carcinoma: Kaplan-Meier analyses showed that mortality was lower in HCC patients with lower MSH2 expression, which was independent of pathological stage, pathologic T classification, tumor grade, vascular invasion, gender, and age (Supplementary Fig. S10).